Alpha 2.0
Login Register
» Authors » Mucho Mizinduko

Mucho Mizinduko

Explore the profile of Mucho Mizinduko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 102
Followers 0
Related Specialties
General Medicine
Infectious Diseases
Science
Top 10 Co-Authors
Doreen Kamori
Werner Maokola
Joan Rugemalila
Kare Moen
George Ruhago
Godfrey Barabona
Jeremiah Mushi
Veryeh Sambu
Amon Sabasaba
Takamasa Ueno
Published In
PLoS One
BMJ Open
Harm Reduct J
J Affect Disord
BMC Endocr Disord
Affiliations
Soon will be listed here.
Recent Articles
1.
HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania
Kamori D, Barabona G, Maokola W, Rugemalila J, Mahiti M, Mizinduko M, et al.
PLoS One . 2024 Aug; 19(8):e0307003. PMID: 39141647
Background: Tanzania has made significant progress in improving access to HIV care and treatment. However, virologic suppression among people living with HIV (PLHIV) has not been fully realized. In March...
2.
HIV burden and the global fast-track targets progress among pregnant women in Tanzania calls for intensified case finding: Analysis of 2020 antenatal clinics HIV sentinel site surveillance
Mboya E, Mizinduko M, Balandya B, Mushi J, Sabasaba A, Amani D, et al.
PLoS One . 2023 Oct; 18(10):e0285962. PMID: 37824470
Background: For successful HIV response, updated information on the burden and progress toward HIV elimination targets are required to guide programmatic interventions. We used data from the 2020 HIV sentinel...
3.
Epidemiology of syphilis infections among pregnant women in Tanzania: Analysis of the 2020 national representative sentinel surveillance
Sunguya B, Mboya E, Mizinduko M, Balandya B, Sabasaba A, Amani D, et al.
PLoS One . 2023 Aug; 18(8):e0285069. PMID: 37651360
Background: Syphilis has detrimental effects on the health of the mother and that of both fetuses and newborns exposed in utero or at delivery. Understanding its local epidemiology is essential...
4.
Low engagement of key populations in HIV health services in Tanzania: analysis of community, legal and policy factors
Kigombola A, Lyimo J, Mizinduko M, Mkembela D, Maziku E, Kafura W, et al.
Pan Afr Med J . 2023 Aug; 45(Suppl 1):8. PMID: 37538366
Introduction: key populations (KP) often face legal and social challenges that increase their vulnerability to HIV. These experiences include criminalization, higher levels of stigma and discrimination which negatively affect access...
5.
Early warning indicators of HIV drug resistance in the southern highlands region of Tanzania: Lessons from a cross-sectional surveillance study
Khamadi S, Mavere C, Bahemana E, Lwilla A, Mizinduko M, Bwigane S, et al.
PLOS Glob Public Health . 2023 Mar; 3(3):e0000929. PMID: 36996096
The World Health Organization early warning indicators (EWIs) permit surveillance of factors associated with the emergence of HIV drug resistance (HIVDR). We examined cross- and within-region performance on HIVDR EWIs...
6.
HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania
Rugemalila J, Kamori D, Kunambi P, Mizinduko M, Sabasaba A, Masoud S, et al.
PLoS One . 2023 Feb; 18(2):e0281528. PMID: 36821538
Background: The emergence of HIV drug resistance mutations (DRMs) is of significant threat to achieving viral suppression (VS) in the quest to achieve global elimination targets. We hereby report virologic...
7.
Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey
Kamori D, Barabona G, Rugemalila J, Maokola W, Masoud S, Mizinduko M, et al.
J Antimicrob Chemother . 2023 Jan; 78(3):779-787. PMID: 36680436
Background: Despite the scale-up of ART and the rollout in Tanzania of dolutegravir, an integrase strand transfer inhibitor (INSTI), treatment success has not been fully realized. HIV drug resistance (HIVDR),...
8.
Testing for Drug-Related Infectious Diseases and Determinants among People Who Use Drugs in a Low-Resource Setting: A Respondent-Driven Cross-Sectional Survey
Likindikoki S, Mmbaga E, Mizinduko M, Alexander M, Adams L, Horsburgh Jr R, et al.
Trop Med Infect Dis . 2022 Sep; 7(9). PMID: 36136624
(1) Background: There is a dearth of data on the levels and determinants of testing for drug-related infectious diseases among people who use drugs (PWUD). We assessed the proportions and...
9.
HIV testing and associated factors among female sex workers in Tanzania: approaching the first 90% target?
Mizinduko M, Moen K, Tersbol B, Likindikoki S, Alexander Ishungisa M, Leyna G, et al.
AIDS Care . 2021 Dec; 35(6):850-858. PMID: 34927487
Use of HIV testing services among FSW in sub-Saharan Africa (SSA) is below the desired UNAIDS target of 90%. We estimated the prevalence and factors associated with HIV testing among...
10.
Acquired HIV drug resistance among children and adults receiving antiretroviral therapy in Tanzania: a national representative survey protocol
Rugemalila J, Kamori D, Maokola W, Mizinduko M, Barabona G, Masoud S, et al.
BMJ Open . 2021 Dec; 11(12):e054021. PMID: 34921085
Introduction: Tanzania is making an enormous effort in scaling-up of antiretroviral therapy (ART). However, people living with HIV (PLHIV) continue to succumb to the challenge of drug resistance. Evidence on...